Altium Capital Management LP Profound Medical Corp. Transaction History

Altium Capital Management LP

$29.1 Million
Q1 2025

A detailed history of Altium Capital Management LP transactions in Profound Medical Corp. stock. As of the latest transaction made, Altium Capital Management LP holds 360,589 shares of PROF stock, worth $2.12 Million. This represents 7.21% of its overall portfolio holdings.

Number of Shares

360,589

Previous 360,589 -0.0%

Holding current value

$2.12 Million

Previous $2.1 Million -0.0%

% of portfolio

7.21%

Previous 7.21%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$5.81 - $7.9 $722,827 - $982,846	-124,411 Reduced 25.65%	360,589 $2.1 Million
Q4 2024 Feb 13, 2025	BUY	$6.98 - $8.96 $3.39 Million - $4.35 Million	485,000 New	485,000 $3.64 Million
Q2 2022 Aug 15, 2022	SELL	$6.34 - $9.53 $792,151 - $1.19 Million	-124,945 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.16 - $11.33 $1.43 Million - $1.98 Million	-175,055 Reduced 58.35%	124,945 $1.13 Million
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $674,700 - $988,000	65,000 Added 27.66%	300,000 $3.37 Million
Q3 2021 Nov 17, 2021	SELL	$13.6 - $17.88 $884,000 - $1.16 Million	-65,000 Reduced 21.67%	235,000 $3.44 Million
Q3 2021 Nov 15, 2021	BUY	$13.6 - $17.88 $1.22 Million - $1.6 Million	89,720 Added 42.67%	300,000 $4.03 Million
Q2 2021 Aug 13, 2021	BUY	$16.0 - $20.59 $1.34 Million - $1.73 Million	83,853 Added 66.33%	210,280 $3.44 Million
Q1 2021 May 06, 2021	BUY	$19.16 - $28.09 $2.42 Million - $3.55 Million	126,427 New	126,427 $2.55 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

13M

Call Options Held

3.3K

Put Options Held

9.3K

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $122M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Account

Altium Capital Management LP Profound Medical Corp. Transaction History